Trump’s 100% tariffs on branded drugs: Indian generics spared but pose risks for pharma sector – Explained

[ad_1] US President Donald Trump‘s announcement of a 100% tariff on imported “branded and patented pharmaceutical products” has rattled the global pharma industry, though Indian generic drug makers are largely expected to remain unaffected for now.Trump, in a post on Truth Social on Thursday, stated: “Starting October 1st, 2025, we will be imposing a 100% […]

Read More

Drug regulator tightens safety norms after cough syrup deaths | India News

[ad_1] BHOPAL: After the death of 23 children in Madhya Pradesh, including 20 from Chhindwara, following the consumption of Coldrif, a cough syrup laced with the killer chemical diethylene glycol (DEG), Drugs Controller General of India (DCGI) Friday made it mandatory to test for both DEG and ethylene glycol (EG) in all raw materials and […]

Read More